Fatty Acid Oxidation Is Preserved Regardless of Impaired Uptake in the Chronically Failing Rat Heart

スポンサーリンク

概要

• 論文の詳細を見る

• Fatty acid is used as a major fuel in the fasting heart, but the precise metabolism in the failing heart remains unknown. We assessed the hypothesis that the fatty acid metabolism might be impaired or delayed during heart failure. We examined in vivo kinetics of an isotope-labeled fatty acid analogue and its substrates as well as hemodynamic parameters and histopathological findings in a rat model of postmyocarditic dilated cardiomyopathy. Rat experimental autoimmune myocarditis (EAM) was induced by injection with porcine cardiac myosin. Rats were treated with quinapril, an angiotensin-converting enzyme inhibitor or vehicle, from the 28th day after healing of myocarditis until the 60th day. On the 61st day, or the compensated chronic heart failure phase, rats were injected with β-methyl-iodophenylpentadecanoic acid (BMIPP) and 15-(p-iodophenyl)-9-methylpentadecanoic acid ([I^<125>] 9MPA), then sacrificed 3, 10, 30, and 60 min later. The hearts were excised, their radioactivities were calculated, and the homogenates were assayed quantitatively on thin layer chromatography. Left ventricular weight was found to increase by 1.6-times and the myocardial area of fibrosis was prominent in chronic heart failure rats. Myocardial uptake of BMIPP and 9MPA decreased by 48～75% in the failing heart; however, the final oxidized product ratio of total 9MPA substrates, p-iodophenylacetic acid (PIPA), increased by 127～136% compared with the normal heart. Quinapril decreased the central venous pressure and left ventricular enddiastolic pressure, but increased the absolute value of the rate of isovolumetric contraction. Quinapril suppressed left ventricular hypertrophy by 70% and decreased the fibrosis area by 35% in this model. Quinapril also improved the initial uptake of fatty acid into the myocardium, but it did not affect the substrate pattern of 9MPA metabolites. Our findings suggest that fatty acid oxidation is preserved regardless of impaired uptake in the chronically failing rat heart and that quinapril is able to correct the uptake of fatty acid into the myocardium.

• 新潟大学の論文
• 2004-03-00

著者

• TACHIKAWA Hitoshi

  First Department of Internal Medicine, Radioisotope Center, Niigata University Graduate School of Medicine:Department of Clinical Pharmacology, Niigata College of Pharmacy

• Tachikawa Hitoshi

  First Department of Internal Medicine, Niigata University Graduate School of Medical and Dental Sciences

関連論文

• Involvement of Mast Cells in the Development of Fibrosis in Rats with Postmyocarditis Dilated Cardiomyopathy(Miscellaneous)
• Changes in the Occurrence of Mechanical Alternans After Long-Term β-Blocker Therapy in Patients With Chronic Heart Failure
• OE-213 Evaluation of Adipocytokines, Proinflammatory Cytokines, and Inflammatory Markers in Coronary Sinus and Hepatic Venous Blood(Coronary circulation, basic/clinical-1 (IHD) OE36,Oral Presentation (English),The 70th Anniversary Annual Scientific Meetin
• Effects of Angiotensin Receptor Blocker on Oxidative Stress and Cardio-Renal Function in Streptozotocin-Induced Diabetic Rats
• Edaravone Inhibits JNK-c-Jun Pathway and Restores Anti-oxidative Defense after Ischemia-Reperfusion Injury in Aged Rats(Pharmacology)
• Cardiac Fatty Acid Metabolism Was Impaired and Delayed in Peroxisome Proliferator Activated Receptor (PPAR) alpha-Null Mice
• Myocardial Intramitochondrial Beta-Oxidative Fatty Acid Metabolism Is Accelerating in Chronic Heart Failure
• Amiodarone Suppressed Left Ventricular Remodeling and Improved Cardiac Function and Sympathetic Function in Chronic Heart Failure after Autoimmune Myocarditis
• Fatty Acid Oxidation Is Preserved Regardless of Impaired Uptake in the Chronically Failing Rat Heart

スポンサーリンク